agilon health, inc. — Director's Dealing 2022

Apr 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: agilon health, inc. (AGL)
CIK: 0001831097
Period of Report: 2022-04-14

Reporting Person: McLoughlin Karen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-14	Common Stock	A	6936	$0.00	Acquired	10425	Direct

Footnotes

F1: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director.

F2: Includes restricted stock units.